Spironolactone to prevent peritoneal fibrosis in peritoneal dialysis patients: A randomized controlled trial

American Journal of Kidney Diseases

Volumn 63, Issue 6, 2014, Pages 1072-1074

  Vazquez Rangel, Armando ^a   Soto, Virgilia ^a   Escalona, Marco ^a   Toledo, Rafael G ^a   Castillo, Edgar A ^a   Polanco Flores, Nasser Abdel ^a   Falcon Chavez, Ilse ^a   Madero, Magdalena ^a  

^a NATIONAL HEART INSTITUTE   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; SPIRONOLACTONE;

ADULT; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; HYPERKALEMIA; IMMUNOHISTOCHEMISTRY; KIDNEY POLYCYSTIC DISEASE; LETTER; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NEPHROLITHIASIS; NEPHROLOGIST; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONITIS; POTASSIUM BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT DURATION;

ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MINERALOCORTICOID RECEPTOR ANTAGONISTS; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; RENIN-ANGIOTENSIN SYSTEM; SPIRONOLACTONE;

EID: 84901503123     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.01.426     Document Type: Letter

References (7)

1. S. Mujais, K. Nolph, and R. Gokal et al. Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis Perit Dial Int 20 suppl 4 2000 S5 S21
2. O. Heimburger, J. Waniewski, and A. Werynski et al. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity Kidney Int 38 3 1990 495 506
3. J.D. Williams, K.J. Craig, and C. von Ruhland et al. The natural course of peritoneal membrane biology during peritoneal dialysis Kidney Int Suppl 88 2003 S43 S49
4. R. Ersoy, A. Celik, and O. Yilmaz et al. The effects of irbesartan and spironolactone in prevention of peritoneal fibrosis in rats Perit Dial Int 27 4 2007 424 431
5. H. Noh, H. Ha, and M.R. Yu et al. Angiotensin II mediates high glucose-induced TGF-beta1 and fibronectin upregulation in HPMC through reactive oxygen species Perit Dial Int 25 1 2005 38 47
6. K. Kiribayashi, T. Masaki, and T. Naito et al. Angiotensin II induces fibronectin expression in human peritoneal mesothelial cells via ERK1/2 and p38 MAPK Kidney Int 67 3 2005 1126 1135
7. K. Metsarinne, F. Fyhrquist, and C. Gronhagen-Riska Increased levels of immunoreactive plasma renin substrate during infectious peritonitis in patients on continuous ambulatory peritoneal dialysis Clin Sci (Lond) 75 4 1988 411 414